J. Cheetham

发表

Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post‐photorefractive keratectomy patients

M. Raizman, R. Schiffman, K. Solomon, 2004, Journal of cataract and refractive surgery.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

F. Ferris, M. Maguire, S. Sadda, 2019, Translational vision science & technology.

Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.

R. Schiffman, Robert D. Williams, T. Walters, 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.

S. Whitcup, R. Gross, John S. Cohen, 2004, Survey of ophthalmology.

Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.

A. Cideciyan, B. Munoz, S. West, 2016, Ophthalmology. Retina.

Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.

J. Sahel, A. Cideciyan, B. Munoz, 2017, Ophthalmology.

Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)

Mark H. Myers, Todd A. Durham, R. Doty, 2021, American journal of medical genetics. Part A.

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

Christina Y Weng, Christina Y. Weng, Todd A. Durham, 2020, Translational vision science & technology.

Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10

A. Cideciyan, B. Munoz, S. West, 2018, JAMA ophthalmology.

Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium

Todd A. Durham, J. Sahel, F. Ferris, 2021, Translational vision science & technology.

Re: Shen et al.: Natural history of autosomal recessive Stargardt disease in untreated eyes: a systematic review and meta-analysis of study and individual level data (Ophthalmology. 2019;126:1288-1296).

B. Munoz, S. West, H. Scholl, 2020, Ophthalmology.

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.

J. Heier, M. Dirks, D. Caldwell, 1999, American journal of ophthalmology.

Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: Functional vision and contrast sensitivity

A. Ginsburg, M. Abelson, J. Cheetham, 1995, Journal of cataract and refractive surgery.

Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

K. Solomon, S. Brint, J. Cheetham, 2001, Ophthalmology.

Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.

J. Cheetham, R. Grosserode, A. Rosenthal, 1999, Clinical therapeutics.

Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.

V. Thompson, S. Brint, J. Cheetham, 1999, Journal of cataract and refractive surgery.

Ocufen (flurbiprofen) in the treatment of ocular pain after radial keratotomy.

A. Gwon, J. Cheetham, R. Degryse, 1994, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

The ocular hypertensive effect of 0.25% fluorometholone in corticosteroid responders.

M. Kass, J. Cheetham, E. Duzman, 1986, American journal of ophthalmology.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Glenn J. Jaffe, Maureen G. Maguire, Sheila K. West, 2019, Translational vision science & technology.

Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.

C. Felix, A. Batoosingh, R. David, 2001, Archives of ophthalmology.

Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group.

D. Shin, R. Frenkel, R. David, 1996, American journal of ophthalmology.

Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases

F. Ferris, E. Chew, J. Duncan, 2017, Investigative ophthalmology & visual science.

Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin

R. Osher, J. Cheetham, L. Amdahl, 1994, Journal of cataract and refractive surgery.

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

Francisco J. López, S. Wolf, G. Staurenghi, 2018, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation with Other Measures of Disease Severity.

Todd A. Durham, J. Sahel, F. Ferris, 2020, American journal of ophthalmology.

Tissue‐specific genotype–phenotype correlations among USH2A‐related disorders in the RUSH2A study

Todd A. Durham, J. Duncan, C. Brewer, 2022, Human mutation.

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease

Beatriz Munoz, Zhihong Hu, Hendrik P. N. Scholl, 2019, Translational vision science & technology.

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel

S. Daiger, L. Sullivan, C. Hoyng, 2023, Translational vision science & technology.

The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene

Todd A. Durham, J. Duncan, K. Stingl, 2022, Investigative ophthalmology & visual science.

Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery

H. Gimbel, J. Cheetham, J. V. van Westenbrugge, 1996, Journal of cataract and refractive surgery.

Reduction of inflammation following cataract surgery by the nonsteroidal anti-inflammatory drug, flurbiprofen.

H. Tessler, J. Cheetham, D. Sabiston, 1987, Ophthalmic surgery.

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire

G. Dagnelie, J. Duncan, K. T. Jayasundera, 2024, Investigative ophthalmology & visual science.